科源制药：拟发行股份购买宏济堂99.42%股权并募集配套资金

Group 1 - The company plans to issue shares to acquire 99.42% equity of Hongjitang from 38 trading parties, including Linuo Investment Holding Group Co., Ltd. and Linuo Group Co., Ltd. [1] - The company intends to raise no more than 700 million yuan through a share issuance to no more than 35 specific investors as supporting funds [1] - The target company's main business includes the research, production, and sales of traditional Chinese medicine and health products, as well as muscone [1]